These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16257852)

  • 1. Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.
    Torrey CE; Wall HG; Campbell JA; Kwanyuen P; Hoivik DJ; Miller RT; Allen JS; Jayo MJ; Selinger K; Santostefano MJ
    Int J Toxicol; 2005; 24(5):327-39. PubMed ID: 16257852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after oral administration--part I.
    Torrey CE; Wall HG; Campbell JA; Kwanyuen P; Hoivik DJ; Miller RT; Allen JS; Jayo MJ; Selinger K; Savina PM; Santostefano MJ
    Int J Toxicol; 2005; 24(5):313-25. PubMed ID: 16257851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.
    Nesfield SR; Clarke CJ; Hoivik DJ; Miller RT; Allen JS; Selinger K; Santostefano MJ
    Int J Toxicol; 2005; 24(5):301-11. PubMed ID: 16257850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the carcinogenic potential of clofibrate in the p53+/- mouse.
    Torrey CE; Campbell JA; Hoivik DJ; Miller RT; Allen JS; Mann PC; Selinger K; Rickert D; Savina PM; Santostefano MJ
    Int J Toxicol; 2005; 24(5):289-99. PubMed ID: 16257849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.
    Nesfield SR; Williams TC; Hoivik DJ; Miller RT; Allen JS; Selinger K; Rickert D; Santostefano MJ
    Int J Toxicol; 2005; 24(5):341-8. PubMed ID: 16257853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical application of representative multifunctional acrylates produced proliferative and inflammatory lesions in F344/N rats and B6C3F1 mice, and squamous cell neoplasms in Tg.AC mice.
    Doi AM; Hailey JR; Hejtmancik M; Toft JD; Vallant M; Chhabra RS
    Toxicol Pathol; 2005; 33(6):631-40. PubMed ID: 16176922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 26-Week dermal oncogenicity study evaluating pure trans-capsaicin in Tg.AC hemizygous mice (FBV/N).
    Chanda S; Erexson G; Frost D; Babbar S; Burlew JA; Bley K
    Int J Toxicol; 2007; 26(2):123-33. PubMed ID: 17454252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components.
    Thompson KL; Rosenzweig BA; Weaver JL; Zhang J; Lin KK; Sistare FD
    Toxicol Sci; 2003 Aug; 74(2):271-8. PubMed ID: 12773758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemizygous Tg.AC transgenic mouse as a potential alternative to the two-year mouse carcinogenicity bioassay: evaluation of husbandry and housing factors.
    Holden HE; Stoll RE; Spalding JW; Tennant RW
    J Appl Toxicol; 1998; 18(1):19-24. PubMed ID: 9526830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
    Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
    Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxymetholone: II. Evaluation in the Tg-AC transgenic mouse model for detection of carcinogens.
    Holden HE; Stoll RE; Blanchard KT
    Toxicol Pathol; 1999; 27(5):507-12. PubMed ID: 10528629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
    Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
    Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tg.AC genetically altered mouse: assay working group overview of available data.
    Eastin WC; Mennear JH; Tennant RW; Stoll RE; Branstetter DG; Bucher JR; McCullough B; Binder RL; Spalding JW; Mahler JF
    Toxicol Pathol; 2001; 29 Suppl():60-80. PubMed ID: 11695563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
    Trempus CS; Haseman JK; Tennant RW
    Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations of clofibrate in alternative carcinogenicity models.
    Santostefano MJ; Hoivik DJ; Miller RT
    Int J Toxicol; 2005; 24(5):285-8. PubMed ID: 16257848
    [No Abstract]   [Full Text] [Related]  

  • 16. Dermal carcinogenicity in transgenic mice: relative responsiveness of male and female hemizygous and homozygous Tg.AC mice to 12-O-tetradecanoylphorbol 13-acetate (TPA) and benzene.
    Blanchard KT; Ball DJ; Holden HE; Furst SM; Stoltz JH; Stoll RE
    Toxicol Pathol; 1998; 26(4):541-7. PubMed ID: 9715513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
    Bhasin G; Kauser H; Athar M
    Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of SEPA 0009-induced tumorigenesis in v-rasHa transgenic Tg.AC mice.
    Fuhrman J; Shafer L; Repertinger S; Chan T; Hansen LA
    Toxicol Pathol; 2005; 33(6):623-30. PubMed ID: 16176921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event.
    Hansen LA; Spalding JW; French JE; Tennant RW
    Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.